|
Volumn 18, Issue 3, 2001, Pages 277-284
|
Development and evaluation of sustained-release propranolol wax microspheres
|
Author keywords
Factorial design; Propranolol; Sustained release; Wax microspheres
|
Indexed keywords
BETA ADRENERGIC RECEPTOR;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CERESIN;
CHLOROFORM;
EMULSIFYING AGENT;
ETHER;
FLUOROURACIL;
GLYCEROL STEARATE;
HYDROCHLORIC ACID;
IBUPROFEN;
MICROCRYSTALLINE WAX;
MICROSPHERE;
POLYSORBATE 20;
POLYSORBATE 80;
POTASSIUM CHLORIDE;
POTASSIUM DIHYDROGEN PHOSPHATE;
PROPOLIS;
PROPRANOLOL;
SODIUM HYDROXIDE;
SULFATHIAZOLE;
UNCLASSIFIED DRUG;
URINARY TRACT ANTIINFECTIVE AGENT;
VALPROIC ACID;
WAX;
ARTICLE;
CHEMICAL ANALYSIS;
CHEMICAL COMPOSITION;
CONTROLLED STUDY;
DISPERSION;
DRUG DELIVERY SYSTEM;
DRUG DOSAGE FORM;
DRUG FORMULATION;
DRUG RELEASE;
DRUG RESEARCH;
DRUG SOLUBILITY;
DRUG SYNTHESIS;
EMULSION;
FACTORIAL ANALYSIS;
IN VITRO STUDY;
INTESTINE ABSORPTION;
MICROENCAPSULATION;
PARTICLE SIZE;
PH MEASUREMENT;
SUSTAINED RELEASE PREPARATION;
ADRENERGIC BETA-ANTAGONISTS;
DELAYED-ACTION PREPARATIONS;
DRUG COMPOUNDING;
HUMANS;
MICROSPHERES;
PARTICLE SIZE;
PROPRANOLOL;
WAXES;
|
EID: 0035068018
PISSN: 02652048
EISSN: None
Source Type: Journal
DOI: 10.1080/02652040010018074 Document Type: Article |
Times cited : (19)
|
References (27)
|